Pascale Leclercq

1.6k total citations
49 papers, 1.1k citations indexed

About

Pascale Leclercq is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Pascale Leclercq has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 16 papers in Emergency Medicine and 12 papers in Virology. Recurrent topics in Pascale Leclercq's work include HIV-related health complications and treatments (16 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (12 papers). Pascale Leclercq is often cited by papers focused on HIV-related health complications and treatments (16 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (12 papers). Pascale Leclercq collaborates with scholars based in France, United Kingdom and Tunisia. Pascale Leclercq's co-authors include Patrice Massip, Y Mouton, Jean Lang, Guy Humbert, S. Alfandari, J Modaï, H. Portier, D. Méchali, P. Dellamonica and M. Valette and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Journal of Comparative Neurology.

In The Last Decade

Pascale Leclercq

46 papers receiving 1.0k citations

Peers

Countries citing papers authored by Pascale Leclercq

Since Specialization

Citations

This map shows the geographic impact of Pascale Leclercq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale Leclercq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale Leclercq more than expected).

Fields of papers citing papers by Pascale Leclercq

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale Leclercq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale Leclercq. The network helps show where Pascale Leclercq may publish in the future.

Co-authorship network of co-authors of Pascale Leclercq

This figure shows the co-authorship network connecting the top 25 collaborators of Pascale Leclercq. A scholar is included among the top collaborators of Pascale Leclercq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale Leclercq. Pascale Leclercq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world effectiveness, safety, and health-related quality of life in people living with HIV receiving bictegravir/emtricitabine/tenofovir alafenamide—12-month results of the BICSTaR French cohort 2025 ·IJID Regions ·Laurent Hocqueloux, Fabrice Bonnet, Claudine Duvivier, Matteo Vassallo, (unknown), Pascale Leclercq, Marina Karmochkine, (unknown), Colin Deschanvres, (unknown), David Thorpe, Tali Cassidy, François Durand, Sabrinel Sahali, Olivier Robineau	0
2	The functions of evidentiality 2024 ·Functions of Language ·(unknown), Pascale Leclercq	0
3	The Acquisition of Verbal Epistemic Stance Marking during Study Abroad: The Case of je pense in L2 French 2021 ·Languages ·Pascale Leclercq	0
4	Influence of the First Consultation on Adherence to Antiretroviral Therapy for HIV-infected Patients 2016 ·The Open AIDS Journal ·(unknown), Aurélie Gauchet, Matthieu Roustit, Pascale Leclercq, Olivier Épaulard	7
5	A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use 2013 ·BMC Infectious Diseases ·Martin Duracinský, Pascale Leclercq, Andrew Armstrong, (unknown), F. Mouly, Olivier Chassany	8
6	High Prevalence and Impact on the Quality of Life of Facial Lipoatrophy and Other Abnormalities in Fat Tissue Distribution in HIV-Infected Patients Treated with Antiretroviral Therapy 2012 ·AIDS Research and Human Retroviruses ·Pascale Leclercq, Cécile Goujard, Martin Duracinský, François‐André Allaert, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gilles Pialoux	25
7	Infection par le virus de l’immunodéficience humaine et diabète : vécu et qualité de vie des patients confrontés à deux maladies chroniques 2011 ·La Presse Médicale ·(unknown), Patricia Pavèse, (unknown), José Labarère, Pascale Leclercq, Jean‐Paul Brion	6
8	Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123--ETOILE) 2010 ·Journal of Antimicrobial Chemotherapy ·Véronique Avettand-Fènoël, Vincent Bouteloup, (unknown), Catherine Fagard, Marie‐Laure Chaix, Pascale Leclercq, Geneviève Chêne, Jean‐Paul Viard, C Rouzioux, (unknown)	12
9	Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women 2008 ·British Journal of Clinical Pharmacology ·Matthieu Roustit, (unknown), Pascale Leclercq, Françoise Stanke‐Labesque	49
10	Le médicament du mois : Etoricoxib (Arcoxia®) 2004 ·RMLG. Revue médicale de Liège ·Pascale Leclercq, Michel Malaise	5
11	Metabolic response to a 13C-glucose load in human immunodeficiency virus patients before and after antiprotease therapy 2002 ·Metabolism ·Marion Korach-André, Pascale Leclercq, François Péronnet, Xavier Leverve	3
12	The mitochondrial consequences of uncoupling intact cells depend on the nature of the exogenous substrate 2001 ·Biochemical Journal ·Brigitte Sibille, Céline Filippi, Marie‐Astrid Piquet, Pascale Leclercq, Éric Fontaine, Xavier Ronot, Michel Rigoulet, Xavier Leverve	9
13	Change in Transaminases in Hepatitis C Virus- and HIV-Coinfected Patients after Highly Active Antiretroviral Therapy: Differences between Complete and Partial Virologic Responders? 2000 ·AIDS Research and Human Retroviruses ·G. Gavazzi, (unknown), Pascale Leclercq, (unknown), A. Bosseray, (unknown), M. Micoud, Patrice Morand	37
14	Association between Primary Cytomegalovirus Infection and Severe Hemolytic Anemia in an Immunocompetent Adult 1999 ·European Journal of Clinical Microbiology & Infectious Diseases ·Pascale Leclercq, M. Micoud, G. Gavazzi, (unknown), A. Bosseray, (unknown)	12
15	Human Herpesvirus 8 and Epstein Barr-Virus in a Cutaneous B-Cell Lymphoma and a Malignant Cell Line Established from the Blood of an AIDS Patient 1999 ·Leukemia & lymphoma ·Patrice Morand, Marlyse Buisson, H. Collandre, B. Chanzy, O. Genoulaz, (unknown), N. Pinel, Pascale Leclercq, Dominique Leroux, Vincent Maréchal, (unknown), Rob W. H. Ruigrok, Jean‐Marie Seigneurin	28
16	Candida Meningitis Possibly Resulting from a Harpoon Injury 1999 ·European Journal of Clinical Microbiology & Infectious Diseases ·Marie‐Pierre Brenier‐Pinchart, Pascale Leclercq, (unknown), G. Bettega	2
17	Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres 1997 ·AIDS ·Y Mouton, S. Alfandari, M. Valette, F Cartier, P. Dellamonica, Guy Humbert, Jean Lang, Patrice Massip, D. Méchali, Pascale Leclercq, J Modaï, H. Portier	313
18	[Health economics and antibiotic therapy]. 1995 ·PubMed ·Pascale Leclercq, Maryam Bigdeli	1
19	Detection ofToxoplasma gondii in AIDS patients by the polymerase chain reaction 1993 ·Infection ·Nadine Cristina, Hervé Pelloux, (unknown), P Ambroise-Thomas, Jean‐Pierre Brion, Pascale Leclercq	21
20	HIV-1 in Blood Monocytes: Frequency of Detection of Proviral DNA Using PCR and Comparison with the Total CD4 Count 1992 ·AIDS Research and Human Retroviruses ·(unknown), Michèle Ottmann, Patrice Morand, Pascale Leclercq, J. M. Seigneurin	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact